期刊文献+

早期子宫颈腺癌盆腔淋巴结转移高危因素分析 被引量:3

The Analysis of High-Risk Factors of Pelvic Lymph Node Metastasis in Early Stage Cervical Adenocarcinoma
下载PDF
导出
摘要 目的:探讨早期子宫颈腺癌盆腔淋巴结转移高危因素,为临床是否切除盆腔淋巴结提供参考。方法:收集418例早期子宫颈腺癌患者临床病理资料,进行单因素及多因素Logistic回归分析盆腔淋巴结转移的高危因素。结果:患者发病年龄18~69岁,孕次0~11次,产次0~5次,体质量指数15.15~32.42 kg/m^2。临床表现以接触性出血及阴道不规则流血多见,分别占43.78%(183/418)及31.10%(130/418)。临床分期以ⅠB1期为主,有244例(58.37%);组织学类型以子宫颈腺癌普通型为主,有219例(52.39%)。患者盆腔淋巴结转移率为17.46%(73/418)。单因素分析发现术前未行新辅助化疗、临床分期、组织学类型、肿瘤直径、子宫颈间质浸润深度、淋巴脉管间隙浸润、宫旁浸润、切缘浸润、阴道浸润、宫体浸润、输卵管转移是盆腔淋巴结转移的影响因素(P<0.05)。多因素Logistic回归分析发现,FIGO临床分期Ⅱ期(OR 3.658,95%CI 1.950~6.680)、子宫颈间质浸润深度≥1/2(OR 4.962,95%CI 2.110~11.669)、淋巴脉管间隙浸润(OR 2.279,95%CI 1.190~4.363)、宫体浸润(OR 2.124,95%CI 1.115~4.047)、输卵管转移(OR 6.429,95%CI 1.473~28.063)是盆腔淋巴结转移的高危因素(P<0.05)。结论:早期子宫颈腺癌患者中,FIGO临床分期Ⅱ期、子宫颈间质浸润深度≥1/2、淋巴脉管间隙浸润、宫体浸润、输卵管转移的子宫颈腺癌患者发生盆腔淋巴结转移可能性大,应行盆腔淋巴结切除术。 Objective:To explore the high-risk factors of pelvic lymph node metastasis in early stage cervical adenocarcinoma patients,and to provide reference for clinical resection of pelvic lymph nodes.Methods:The clinicopathological data of 418 patients with early stage cervical adenocarcinoma were collected.The high-risk factors of pelvic lymph node metastasis were analyzed by univariate and logistic regression analysis.Results:The age of the patients ranged from 18 to 69 years old with the number of pregnancies ranged from 0 to 11 and births ranged from 0 to 5,and the body mass index ranged from 15.15 to 32.42 kg/m^2.Contact hemorrhage(43.78%,183/148)and irregular vaginal bleeding(31.10%,130/148)were the most common clinical manifestations,and the numbers were 183 and 130 cases respectively.The clinical stage was mainlyⅠB1,with 244 cases(58.37%)and the histological type was mainly endocervical adenocarcinomausual type,with 219 cases(52.39%).The rate of pelvic lymph node metastasis was 17.46%(73/418).Univariate analysis showed that without neoadjuvant chemotherapy,clinical stage,histological type,tumor diameter,cervical interstitial infiltration,lymphatic vessel space infiltration,parametrial infiltration,margin of incision infiltration,vaginal infiltration,uterine body infiltration and fallopian tube metastasis were the high-risk factors for pelvic lymph node metastasis(P<0.05).Multivariate logistic regression analysis showed that FIGO stageⅡ(OR 3.658,95%CI 1.950-6.680),cervical interstitial infiltration(≥1/2)(OR 4.962,95%CI 2.110-11.669),lymphatic vessel space infiltration(OR 2.279,95%CI 1.190-4.363),uterine body infiltration(OR 2.124,95%CI 1.115-4.047)and fallopian tube metastasis(OR 6.429,95%CI 1.473-28.063)were independent high-risk factors for pelvic lymph node metastasis(P<0.05).Conclusions:Cervical adenocarcinoma patients with FIGO stageⅡ,cervical interstitial infiltration(≥1/2),lymphatic vessel space infiltration,uterine body infiltration and fallopian tube metastasis were more likely to have pelvic lymph node metastasis,and pelvic lymphadenectomy should be performed.
作者 易启华 陈琳 郑莹 陈思敬 徐流凤 董诗萌 YI Qihua;CHEN Lin;ZHENG Ying(Department of Gynecology,West China Second University Hospital,Chengdu Sichuan 610041,China;Department of Gynecology,Chongqing University Three Gorges Hospital,Chongqing 404100,China)
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2020年第8期606-609,共4页 Journal of Practical Obstetrics and Gynecology
关键词 早期子宫颈腺癌 临床病理特征 盆腔淋巴结转移 高危因素 Early stage cervical adenocarcinoma Clinicopathological characteristics Pelvic lymph node metastasis High-risk factors
  • 相关文献

参考文献5

二级参考文献30

  • 1李华,章文华,张蓉,吴令英,李晓光,白萍.子宫颈腺癌159例预后影响因素分析[J].中华妇产科杂志,2005,40(4):235-238. 被引量:19
  • 2Kokawa K, Takekida S, Kamiura S, et al. The incidence, treatment and prognosis of cervical carcinoma in young women: a retrospec- tive analysis of 4,975 cases in Japan[J]. EurJ Gynaecol Oncol, 2010, 31(1): 37-43.
  • 3Hovland S, Muller S, Skomedal H, et al. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcino- ma in clinical prognostic procedure[J]. Int J Oncol, 2010, 36(6): 1533-1539.
  • 4Howlett R.I, Marrentt LD, Innes MK, et al. Decreasing incidence of cervical adenocarcinoma in Ontario: Is this related to improved en- docervical Pap test sampling[J]? IntJ Cancer, 2006, 120: 362--367.
  • 5Vesco KK, Whitlock EP, Eder M, et al. Risk Factors and Other Epi demiologic Considerations for Cervical Cancer Screening: A Narra five Review for the U.S. Preventive Services Task Force[J].Ann In ternal Med, 2011, 155(10): 698-705.
  • 6Jemal A, Siegel R, XuJ, et al. Cancer statistics, 2010[J].Ca CancerJ Clin, 2010, 60(5): 277--300.
  • 7Kokawa K, Takekida S, Kamiura S, et al. The incidence, treatment and prognosis of cervical carcinoma in young women: a retrospec- tive analysis of 4,975 cases in Japan[J]. European journal of gynaeco- ligical oncology, 2010, 31(1): 37-43.
  • 8Hovland S, Muller S, Skomedal H, et al. E6/E7 mRNA expression analysis: A test for the objective assessment of cervical adenocarci- noma in clinical prognostic procedure[J]. InternationJournal of On- cology, 2010, 36(6): 1533-1539.
  • 9Shimada M, Kigawa J, Nishimura R, et al. Ovarian metastases in carcinoma of the uterine cervix[J]. Gynecologic Oncology, 2006, 101(2) : 234-237.
  • 10Lilian TG, Beauchemin MC, Thomas G. Adenocarcinoma: A unique cervical cancer[J].Gynecologic Oncology, 2010, 116(1): 140-146.

共引文献26

同被引文献44

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部